Prognostic impact of lipoprotein(a) levels during lipid management with statins after ST-elevation acute myocardial infarction-Reference-Cited by-同舟云学术

Prognostic impact of lipoprotein(a) levels during lipid management with statins after ST-elevation acute myocardial infarction

Published:2019-12 Issue:8 Volume:30 Page:600-607
ISSN:0954-6928
Container-title:Coronary Artery Disease
language:en
Short-container-title:

Author:

Mitsuda Takayuki,Uemura Yusuke,Ishii Hideki,Tanaka Akihito,Takemoto Kenji,Koyasu Masayoshi,Ishikawa Shinji,Shibata Rei,Watarai Masato,Murohara Toyoaki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference40 articles.

1. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI registry study.;Takii;Circ J,2010

2. Population trends in the incidence and outcomes of acute myocardial infarction.;Yeh;N Engl J Med,2010

3. Incidence, predictors, and subsequent mortality risk of recurrent myocardial infarction in patients following discharge for acute myocardial infarction.;Nakatani;Circ J,2013

4. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.;Baigent;Lancet,2010

5. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis.;Silverman;JAMA,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of elevated lipoprotein (a) in patients with acute coronary syndromes: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-05-09

2. RNA interference-based therapies for atherosclerosis: Recent advances and future prospects;Progress in Molecular Biology and Translational Science;2023

3. Pharmacokinetics, Pharmacodynamics, and Tolerability of Olpasiran in Healthy Japanese and Non-Japanese Participants: Results from a Phase I, Single-dose, Open-label Study;Clinical Therapeutics;2022-09

4. RNA interference-based therapies for the control of atherosclerosis risk factors;Current Opinion in Cardiology;2022-07-12

5. Effect of lipoprotein(a) levels on long-term outcome in octogenarians with coronary artery disease after drug-eluting stent implantation;Reviews in Cardiovascular Medicine;2022-03-01